Paclitaxel combined with siRNA complexes against VEGF and PlK-1 was used in studies using multifunctional cationic micelles [35,36], resulting in increased endocytosis in tumor cells and higher tumor suppression. This evidence concerns the gene PLK1 and neoplasm.